Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents

Mostrar otras versiones (1)

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the third coronavirus in less than 20 years to spillover from an animal reservoir and cause severe disease in humans. High impact respiratory viruses such as pathogenic beta-coronaviruses and influenza viruses, as well as other emerging...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarkoob, Hoda, Allué-Guardia, Anna, Chen, Yu-Chi, Jung, Olive, Garcia-Vilanova, Andreu, Song, Min Jae, Park, Jun-Gyu, Oladunni, Fatai, Miller, Jesse, Tung, Yen-Ting, Kosik, Ivan, Schultz, David, Yewdell, Jonathan, Torrelles, Jordi B., Martinez-Sobrido, Luis, Cherry, Sara, Ferrer, Marc, Lee, Emily M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132232/
https://www.ncbi.nlm.nih.gov/pubmed/34013274
http://dx.doi.org/10.1101/2021.05.11.443693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132232/
https://www.ncbi.nlm.nih.gov/pubmed/34013274
http://dx.doi.org/10.1101/2021.05.11.443693

Ejemplares similares